Onshore yuan closed at 6.7779 per U.S. dollar at 16:30 on July 14, up 38 pips from the previous trading day.

Southern's 2x leveraged long position on SK Hynix (07709) widened losses to 10%.

China's National Healthcare Security Administration announced 601 drugs passed form review for the 2026 national basic medical insurance, maternity and work-injury drug-list adjustment. For the basic insurance list the NHSA received 800 submissions covering 664 generic names; 601 passed form review — 233 were in-list candidates and 368 off-list candidates — a 91% pass rate. For the commercial health insurance innovative-drug list it received 62 submissions covering 62 generics; 58 passed form review (1 in-list, 57 off-list), a 94% pass rate. The NHSA said form review is an initial eligibility check for expert assessment and does not constitute inclusion in the drug lists.